Latest filing published 17 Mar 2015 for Adamas Pharmaceuticals Inc, €5.7M.
Insider track record
No signal scores available.
aeris Capital Equity Investments, L.P.: trading record in brief
All filings by aeris Capital Equity Investments, L.P. on record concern Adamas Pharmaceuticals Inc. We count 11 filings; the first trade dates from 15 April 2014 and the latest from 13 March 2015.
The open-market record consists of 10 sales worth €7.6M, with no purchase. So far in 2015, the count stands at no purchases and 1 sale.
Most recently, on 17 March 2015, the filings show an open-market sale worth €5.7M in Adamas Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to aeris Capital Equity Investments, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 350,000 shares@ US$17.23Common StockSEC:0001209191-15-026796:0
- 6,400 shares@ US$14.51Common StockSEC:0001181431-14-038038:0
- 105,225 shares@ US$14.51Common StockSEC:0001181431-14-038038:1
- 800 shares@ US$14.93Common StockSEC:0001181431-14-037661:0
- 12,815 shares@ US$14.51Common StockSEC:0001181431-14-037661:1
- 12,500 shares@ US$14.77Common StockSEC:0001181431-14-037463:0
- 4,400 shares@ US$14.86Common StockSEC:0001181431-14-037413:0
- 5,600 shares@ US$14.85Common StockSEC:0001181431-14-037413:1
- 8,760 shares@ US$14.82Common StockSEC:0001181431-14-037335:0
- 3,500 shares@ US$14.69Common StockSEC:0001181431-14-037189:0
- 1,104,596 sharesCommon StockSEC:0001209191-14-027519:0
11 of 11 declarations
